Skip to content

Clinical trials

Completed Phase 1/2 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 1/2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20093
20103
20112
20122
20131
20141
20162
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Santen Inc.3
Allergan2
Bausch & Lomb Incorporated2
Alcon Research1
Danube Pharmaceuticals, Inc.1
ForSight Vision5, Inc.1
Inotek Pharmaceuticals Corporation1
Kubota Vision Inc.1
Lexicon Pharmaceuticals1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension18
Glaucoma12
Glaucoma, Open-Angle12

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.